709 reports of this reaction
6.1% of all BARICITINIB reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for BARICITINIB, manufactured by Eli Lilly and Company. There are 709 FDA adverse event reports linking BARICITINIB to DRUG INEFFECTIVE. This represents approximately 6.1% of all 11,538 adverse event reports for this drug.
Patients taking BARICITINIB who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among BARICITINIB users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for BARICITINIB:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 709 FDA reports for BARICITINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 6.1% of all adverse event reports for BARICITINIB, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking BARICITINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.